A Canada-based, family-owned investment firm with a background in manufacturing invests in both public and private companies across a variety of industries, including healthcare and biotechnology. For private investments, the firm’s typical check size ranges from $1 million to $5 million. The firm generally prefers participating in investment rounds rather than leading them and primarily focuses on opportunities in North America.
The firm is industry-agnostic and open to opportunities across medtech, biotech, digital health, and healthtech. The investor prefers companies that are closer to commercialization rather than those in the preclinical or early clinical stages, where it can leverage its expertise in commercialization and revenue growth to support portfolio companies.
The firm does not have specific company or management team requirements, although founding teams with successful track records are viewed favorably.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
